Talpa Farma SRL
Talpa Farma reported total assets of 547,932 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
The score of Talpa Farma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +149 % Total assets +15 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Talpa Farma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 117,741 € | ||||
| Equity | 432,711 € | ||||
| Cash | 189,272 € | ||||
| EBITDA | 204,683 € | ||||
| Total assets | 547,932 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 24 Jun 2025
- Year ended 31 Dec 2023filed on 04 Jul 2024
- Year ended 31 Dec 2022filed on 27 Jun 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
Talpa Farma's financial analysis
- Solvency79.0%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Talpa Farma
Talpa Farma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0686.929.353
- VAT number
- BE0686929353
- Peppol
- Registered · 0208:0686929353 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Dec 2017
- Registered office
- 1070 Anderlecht
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Talpa Farma (SRL) has been based in Anderlecht since 2017, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 117,741 € and equity of 432,711 €; its revenue is not published. Its solvency stands at 79.0%, above the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Talpa Farma
Companies in the same business, of comparable size and area, outside its group.
- Am Investment-Apotheek van Symaeys Retail sale of pharmaceutical products Avelgem · balance sheet 519,305 €
- Benepharma Retail sale of pharmaceutical products Overijse · balance sheet 813,930 €
- Mancha Retail sale of pharmaceutical products Edegem · balance sheet 264,945 €
- Pharmacie de Forest National Retail sale of pharmaceutical products Forest · balance sheet 256,379 €
- Herseltpharma Retail sale of pharmaceutical products Herselt · balance sheet €1.31m
- Vanlerberghe Invest Retail sale of pharmaceutical products Torhout · balance sheet €1.38m
- Global-E-Care Retail sale of pharmaceutical products Antwerp · balance sheet €1.41m
- Camba-Pharma Retail sale of pharmaceutical products Ghent · balance sheet 437,825 €
Frequently asked questions about Talpa Farma
What is the revenue of Talpa Farma?
Talpa Farma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Talpa Farma?
In Belgium, the VAT number is the company number prefixed with BE: BE0686929353 for Talpa Farma, if the company is VAT-registered. Its company number (CBE) is 0686.929.353.
Where is the registered office of Talpa Farma?
According to the CBE register, the registered office of Talpa Farma is in 1070 Anderlecht.
What is the equity of Talpa Farma?
At the close of the 2025 financial year, the equity of Talpa Farma amounts to 432,711 €, a solvency of 79.0% of total assets.
Who manages Talpa Farma?
The register lists 1 active mandates at Talpa Farma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Talpa Farma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →